Checchi Capital Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Sell
4,091
-2,637
-39% -$213K 0.01% 468
2026
Q1
$583K Buy
6,728
+1,168
+21% +$112K 0.03% 323
2025
Q4
$534K Buy
5,560
+45
+0.8% +$4.37K 0.03% 306
2025
Q3
$525K Sell
5,515
-964
-15% -$88.6K 0.03% 313
2025
Q2
$565K Sell
6,479
-252
-4% -$21.4K 0.03% 309
2025
Q1
$605K Buy
6,731
+547
+9% +$48.9K 0.03% 293
2024
Q4
$494K Sell
6,184
-97
-2% -$8.4K 0.03% 329
2024
Q3
$566K Buy
6,281
+327
+5% +$27.5K 0.03% 303
2024
Q2
$469K Sell
5,954
-888
-13% -$72.8K 0.02% 336
2024
Q1
$596K Buy
6,842
+631
+10% +$53.9K 0.05% 288
2023
Q4
$512K Sell
6,211
-733
-11% -$55.9K 0.04% 304
2023
Q3
$544K Buy
6,944
+63
+0.9% +$5.27K 0.05% 271
2023
Q2
$606K Buy
6,881
+18
+0.3% +$1.55K 0.05% 252
2023
Q1
$553K Sell
6,863
-928
-12% -$75.6K 0.05% 265
2022
Q4
$606K Sell
7,791
-4,519
-37% -$366K 0.06% 230
2022
Q3
$994K Sell
12,310
-460
-4% -$41.3K 0.09% 153
2022
Q2
$1.18M Buy
12,770
+1,470
+13% +$149K 0.1% 144
2022
Q1
$1.25M Buy
11,300
+326
+3% +$34.4K 0.11% 136
2021
Q4
$1.14M Sell
10,974
-682
-6% -$79K 0.1% 139
2021
Q3
$1.46M Buy
11,656
+143
+1% +$18.5K 0.14% 114
2021
Q2
$1.43M Sell
11,513
-843
-7% -$106K 0.14% 121
2021
Q1
$1.46M Buy
12,356
+98
+0.8% +$11.5K 0.14% 113
2020
Q4
$1.44M Buy
12,258
+655
+6% +$72.1K 0.15% 114
2020
Q3
$1.21M Sell
11,603
-1,517
-12% -$152K 0.13% 112
2020
Q2
$1.2M Buy
13,120
+1,109
+9% +$106K 0.14% 104
2020
Q1
$1.08M Buy
12,011
+1,469
+14% +$156K 0.1% 93
2019
Q4
$1.2M Buy
10,542
+317
+3% +$34.8K 0.16% 100
2019
Q3
$1.11M Sell
10,225
-302
-3% -$31.5K 0.14% 98
2019
Q2
$1.02M Buy
10,527
+36
+0.3% +$3.29K 0.13% 106
2019
Q1
$956K Sell
10,491
-435
-4% -$38.9K 0.11% 109
2018
Q4
$994K Sell
10,926
-100
-0.9% -$9.35K 0.13% 91
2018
Q3
$1.08M Buy
11,026
+695
+7% +$64.3K 0.13% 110
2018
Q2
$884K Buy
10,331
+405
+4% +$33.8K 0.11% 120
2018
Q1
$796K Buy
9,926
+441
+5% +$36.4K 0.1% 128
2017
Q4
$766K Sell
9,485
-9
-0.1% -$721 0.1% 131
2017
Q3
$738K Buy
9,494
+372
+4% +$30.9K 0.07% 121
2017
Q2
$810K Sell
9,122
-791
-8% -$66.7K 0.09% 112
2017
Q1
$799K Sell
9,913
-924
-9% -$72.2K 0.09% 115
2016
Q4
$772K Sell
10,837
-67
-0.6% -$5.26K 0.1% 112
2016
Q3
$942K Buy
10,904
+1,989
+22% +$173K 0.11% 90
2016
Q2
$774K Buy
8,915
+234
+3% +$18.9K 0.09% 99
2016
Q1
$651K Buy
8,681
+38
+0.4% +$2.86K 0.14% 118
2015
Q4
$665K Sell
8,643
-886
-9% -$66.7K 0.17% 114
2015
Q3
$638K Buy
9,529
+550
+6% +$40.5K 0.17% 108
2015
Q2
$665K Buy
8,979
+531
+6% +$40.6K 0.18% 108
2015
Q1
$659K Buy
8,448
+1,650
+24% +$125K 0.19% 104
2014
Q4
$491K Buy
6,798
+514
+8% +$35.7K 0.18% 120
2014
Q3
$389K Buy
6,284
+2,786
+80% +$177K 0.16% 125
2014
Q2
$223K Buy
+3,498
New +$212K 0.1% 209

Other funds holding MDT

Checchi Capital Advisers's MDT Position: Q2 2026 in Review

Checchi Capital Advisers reduced its Medtronic (MDT) stake by 39% in Q2 2026, selling an estimated $213K and leaving 4,091 shares worth $320K. The position accounts for 0.01% of the portfolio, ranked #468.

Checchi Capital Advisers first reported a position in MDT in Q2 2014 and has held it in 49 quarters since. The position peaked at $1.46M in Q3 2021. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Checchi Capital Advisers held 4,091 shares of Medtronic worth $320K as of Q2 2026.
  • Checchi Capital Advisers sold 2,637 Medtronic shares in Q2 2026, an estimated $213K.
  • Medtronic made up 0.01% of Checchi Capital Advisers's portfolio in Q2 2026, its #468 holding.
  • Checchi Capital Advisers first reported a position in Medtronic in Q2 2014 and has held it in 49 quarters since.
  • Checchi Capital Advisers's Medtronic position peaked at $1.46M in Q3 2021.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.